Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Stepan, JJ; Burr, DB; Li, J; Ma, YL; Petto, H; Sipos, A; Dobnig, H; Fahrleitner-Pammer, A; Michalská, D; Pavo, I.
Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis.
Osteoporos Int. 2010; 21(12): 2027-2036.
Doi: 10.1007/s00198-009-1168-7
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-Autor*innen der Med Uni Graz
-
Dobnig Harald
-
Fahrleitner-Pammer Astrid
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
-
Adult -
-
Aged -
-
Alendronate - therapeutic use
-
Biological Markers - blood
-
Biopsy -
-
Bone Density - drug effects
-
Bone Density Conservation Agents - therapeutic use
-
Bone Remodeling - drug effects
-
Drug Substitution -
-
Female -
-
Femur Neck - physiopathology
-
Humans -
-
Lumbar Vertebrae - physiopathology
-
Middle Aged -
-
Osteogenesis - drug effects
-
Osteoporosis, Postmenopausal - drug therapy
-
Teriparatide - therapeutic use
-
Treatment Outcome -
- Find related publications in this database (Keywords)
-
Alendronate
-
Biochemical markers
-
Bone turnover
-
Histomorphometry
-
Osteoporosis
-
Teriparatide